Argos Therapeutics Inc (NASDAQ:ARGS)

--
Real-Time Quote
As of --
-- -- / --
Today’s Change
0.25
Today|||52-Week Range
11.60
--
Year-to-Date
No recent news for Argos Therapeutics Inc.

Today’s Trading

Previous close0.27
Today’s open--
Day’s range-- - --
Volume--
Average volume (3 months)793,016
Market cap$6.1M
Data as of --

Growth & Valuation

Earnings growth (last year)+54.64%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+82.41%
P/E ratio--
Price/Sales165.87
Price/Book0.46

Competitors

 Today’s
change
Today’s
% change
HEBHemispherx Biopharma...-0.04-10.79%
----
ITUSITUS Corp-0.17-4.39%
ACHVAchieve Life Science...0.000.00%
Data as of 12:31pm ET, 04/25/2018

Financials

Next reporting dateMay 16, 2018
EPS forecast (this quarter)-$1.80
Annual revenue (last year)$945.5K
Annual profit (last year)-$53.0M
Net profit margin-5,608.66%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jeffrey D. Abbey
CFO, Vice President &
Investor Relations Contact
Richard D. Katz
Corporate headquarters
Durham, North Carolina

Forecasts